News: Cipla Ltd (CIPL.BO)

CIPL.BO on Bombay Stock Exchange

617.60INR
19 Dec 2014
Price Change (% chg)

Rs-7.50 (-1.20%)
Prev Close
Rs625.10
Open
Rs631.60
Day's High
Rs634.15
Day's Low
Rs616.70
Volume
84,105
Avg. Vol
195,959
52-wk High
Rs671.95
52-wk Low
Rs366.70

Search Stocks
Select another date:

Wed, Dec 17 2014

Photo

Novartis sues India's Cipla over respiratory drug Onbrez

MUMBAI - Swiss drugmaker Novartis AG said on Wednesday it had sued India's Cipla Ltd for infringing patents covering its respiratory drug Onbrez, a month after Cipla launched a copy at a fifth of the original drug's price.

Novartis sues India's Cipla over respiratory drug Onbrez

MUMBAI, Dec 17 - Swiss drugmaker Novartis AG said on Wednesday it had sued India's Cipla Ltd for infringing patents covering its respiratory drug Onbrez, a month after Cipla launched a copy at a fifth of the original drug's price.

BRIEF-Meda and Cipla sue Apotex to enforce Dymista patents

* Meda and cipla sue apotex to enforce dymista patents Link to press release: http://news.cision.com/meda/r/meda-and-cipla-sue-apotex-to-enforce-dymista--patents,c9690543 Further company coverage:

India's Cipla to market Serum Institute's paediatric vaccines in Europe

MUMBAI, Nov 20 - India's Cipla Ltd said it has agreed to market paediatric vaccines made by Serum Institute of India Ltd in Europe, in a move that marks India's fourth-largest drugmaker's entry into the vaccines space.

UPDATE 2-India's Sun Pharma Q2 profit up 15 pct; Cipla down on slowing exports

* Sun Q2 profit up 15 pct, roughly in line with street estimates

Cipla asks India to revoke Novartis patents on respiratory drug

MUMBAI - Generic drugmaker Cipla Ltd said on Thursday it has asked the Indian government to revoke five patents held by Swiss firm Novartis AG on respiratory drug Onbrez and has launched a cheaper copy to boost access in the local market.

UPDATE 1-Cipla asks India to revoke Novartis patents on respiratory drug

* Cipla says launched cheaper copy of Novartis drug in Delhi

India's Cipla asks government to revoke Novartis patents on respiratory drug

MUMBAI, Oct 30 - Generic drugmaker Cipla Ltd said on Thursday it had requested the Indian government to revoke five patents held by Swiss firm Novartis AG on respiratory drug Onbrez, to boost its access in the Indian market.

INDIA PRESS-Cipla asks government to revoke five patents held by Novartis - Economic Times

Note: Reuters has not verified this story and does not vouch for its accuracy. (Compiled by Derek Francis in Bangalore)

Indian drugmaker Cipla to set up manufacturing plant in Iran

MUMBAI, Oct 7 - Indian generic drugmaker Cipla Ltd has agreed to set up a manufacturing plant in Iran, as part of its strategy to boost its presence in the country's $4 billion pharmaceuticals market that is growing at about 13 percent annually.

Select another date:

Press Releases

Search Stocks